ArticleTechnology in cancer research & treatment

Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center Experience.

Michael Leisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.